Evidence-based medicine or just a theory?

被引:0
作者
Kol, Shahar [1 ]
Lightman, Avraham [1 ]
Itskovitz-Eldor, Joseph [1 ]
机构
[1] Rambam Med Ctr, Dept Obstet & Gynecol, Vitro Fertilizat Unit, IL-31096 Haifa, Israel
关键词
REDUCE OVARIAN DAMAGE; HODGKIN LYMPHOMA; FEMALE-PATIENTS; GNRH AGONISTS; CHEMOTHERAPY;
D O I
10.1016/j.fertnstert.2009.03.070
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
引用
收藏
页码:E9 / E9
页数:1
相关论文
共 7 条
  • [1] RETRACTED: Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study (Retracted article. See vol. 120, pg. 395, 2023)
    Badawy, Ahmed
    Elnashar, Aboubakr
    El-Ashry, Mohamed
    Shahat, May
    [J]. FERTILITY AND STERILITY, 2009, 91 (03) : 694 - 697
  • [2] GnRH agonist therapy as ovarian protectants in female patients undergoing chemotherapy: a review of the clinical data
    Beck-Fruchter, R.
    Weiss, A.
    Shalev, E.
    [J]. HUMAN REPRODUCTION UPDATE, 2008, 14 (06) : 553 - 561
  • [3] Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with hodgkin lymphoma
    Blumenfeld, Zeev
    Avivi, Irith
    Eckman, Ari
    Epelbaum, Ron
    Rowe, Jacob M.
    Dann, Eldad J.
    [J]. FERTILITY AND STERILITY, 2008, 89 (01) : 166 - 173
  • [4] Trying to reduce ovarian damage in patients with Hodgkin lymphoma using GnRH agonists? Reply
    Blumenfeld, Zeev
    [J]. FERTILITY AND STERILITY, 2009, 91 (01) : 299 - 299
  • [5] Preservation of ovarian function in young women treated with neoadjuvant chemotherapy for breast cancer: A randomized trial using the GnRH agonist (triptorelin) during chemotherapy
    Ismail-Khan, R.
    Minton, S.
    Cox, C.
    Sims, I.
    Lacevic, M.
    Gross-King, M.
    Xu, P.
    Carter, B.
    Munster, P. N.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [6] Gonadotropin-releasing hormone analogs in fertility preservation -: lack of biological basis?
    Oktay, Kutluk
    Soenmezer, Murat
    [J]. NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2008, 4 (09): : 488 - 489
  • [7] Trying to reduce ovarian damage in patients with Hodgkin lymphoma using GnRH agonists?
    Oktay, Kutluk
    Sonmezer, Murat
    Barad, David
    Gleicher, Norbert
    [J]. FERTILITY AND STERILITY, 2009, 91 (01) : 298 - 299